Investor Relations

Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer™), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

Recent Releases

Sep 2, 2010
Medidata Solutions to Present at the Deutsche Bank Technology Conference

Aug 31, 2010
PharmaNet Joins Medidata Solutions' CRO Partner Program

View all releases »

Featured Documents

Q2 2010 Supplemental Financial Information

2009 Annual Report

2010 Proxy Statement

2009 Reconciliation Table

Events & Presentations

Sep 15, 2010 at 11:05 AM ET
Deutsche Bank Securities Inc. Technology Conference

Aug 12, 2010 at 5:00 PM ET
Medidata Q2 2010 Conference Call and Webcast

View all events & presentations »